A Novel Nonpeptide HIV-1 Protease Inhibitor: Elucidation of the Binding Mode and Its Application in the Design of Related Analogs
Citations Over TimeTop 10% of 1994 papers
Abstract
HIV-1 protease has been identified as a significant target enzyme in AIDS research. While numerous peptide-derived inhibitors have been described, the identification of a nonpeptide inhibitor remains an important goal. Using an HIV-1 protease mass screening technique, 4-hydroxy-3-(3-phenoxypropyl)-2H-1-benzopyran-2-one (1) was identified as a nonpeptide competitive inhibitor of the enzyme. Employing a Monte Carlo-based docking procedure, the coumarin was docked in the active site of the enzyme, revealing a binding mode that was later confirmed by the X-ray crystal analysis. Several analogs were prepared to test the binding interactions and improve the overall binding affinity. The most active compound in the study was 4,7-dihydroxy-3-[4-(2-methoxyphenyl)butyl]-2H-1-benzopyran-2-one (31).
Related Papers
- → Nine Crystal Structures Determine the Substrate Envelope of the MDR HIV-1 Protease(2011)24 cited
- → Models of HIV-1 protease with peptides representing its natural substrates(1998)7 cited
- → Deep recurrent neural networks in HIV-1 protease cleavage classification(2017)3 cited
- → Deep recurrent neural networks in HIV-1 protease cleavage classification(2017)1 cited
- → Determination of the Substrate Envelope for Multidrug‐Resistant HIV‐1 Protease(2008)